Status:
COMPLETED
Fluorescent Visualization in Early Oral Cancer
Lead Sponsor:
University of Calgary
Collaborating Sponsors:
Terry Fox Research Institute
Conditions:
Oral Squamous Cell Carcinoma or Severe Dysplasia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Studies from Vancouver show that fluorescent visualization (FV) is a useful method of controlling surgical margins. This early finding will now be confirmed in a national randomized controlled trial.
Eligibility Criteria
Inclusion
- biopsy proven invasive oral cancer or severe dysplasia / Cis
- invasive cancer must be T1 or T2
- no prior history of oral cancer / treatment of oral cancer
Exclusion
- prior history of oral cancer
- unable to provide informed consent
- lesion not able to be completely visualized by FV
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02306967
Start Date
September 1 2011
End Date
December 1 2017
Last Update
May 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Foothills Hospital
Calgary, Alberta, Canada, T2N 4N1